Ring 1
Ring 2
Ring 3
Ring 4


Financing Round

  • Series B
Round Led by Symbiosis

SalioGen Therapeutics has launched Gene CodingTM, a genetic medicine platform, to develop durable, broadly applicable genetic medicines, using its Exact DNA Integration Technology™ (EDIT™) platform. EDIT is based on the novel mammal-derived genomic engineering tool, for use in potentially curative genetic medicines. SalioGen is focused on developing therapies for more patients with inherited diseases that are beyond what is addressable with current technologies, initially focusing on inherited macular disorders and inherited lipid disorders.

saliogen View Website


  • Genetic Medicine


  • Circulatory & Metabolic Disease
  • Other

Development Status

  • Pre-Clinical